Valuation: Tyche Industries Limited

Market Cap 1.02B 10.68M 9.15M 8.56M 7.83M 14.77M 14.93M 101M 39.39M 513M 40.09M 39.23M 1.7B P/E 2024
14.7x
P/E 2025 11x
Enterprise Value 983M 10.26M 8.8M 8.23M 7.52M 14.2M 14.35M 97.36M 37.86M 493M 38.53M 37.7M 1.63B EV / Sales 2024
2.53x
EV / Sales 2025 2x
Free-Float
28.55%
Yield 2024
1.42%
Yield 2025 2.25%
08-11 Tyche Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
05-28 Tyche Industries Limited Recommends A Final Dividend for the Year Ended 31 March 2026 CI
05-28 Tyche Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
03-24 Tyche Industries received certificate of GMP compliance from Brazilian agency for facility at Kakinada RE
02-12 Tyche Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
11-13 Tyche Industries Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
25-10-01 Tyche Industries Limited Appoints Sandeep Gokaraju as Managing Director CI
25-10-01 Tyche Industries Limited Declares Dividend for the Financial Year Ended March 31, 2025 CI
25-10-01 Tyche Industries Limited Announces Board Appointments, Effective September 30, 2025 CI
25-09-05 Tyche Industries Limited Approves Redesignation of Mr. G Ganesh Kumar as Chairman and Managing Director to Continue as Executive Director with Effect from September 5, 2025 CI
25-09-05 Tyche Industries Limited Approves Redesignation of Mr. G Ganesh Kumar from Chairman and Managing Director and to Continue as Executive Director with Effect from Close of Business Hours September 5, 2025 CI
25-08-12 Tyche Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
25-05-28 Tyche Industries Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2025 CI
1 day+2.74%
1 week+2.20%
Current month-12.42%
1 month-16.33%
3 months-16.98%
6 months-7.93%
Current year-7.81%
1 week 101.25
Extreme 101.25
109
1 month 101.25
Extreme 101.25
132.4
Current year 99
Extreme 99
148
1 year 99
Extreme 99
148
3 years 99
Extreme 99
230
5 years 99
Extreme 99
230
10 years 35.95
Extreme 35.95
349.9
Manager TitleAgeSince
Chief Executive Officer 43 2025-09-04
Director of Finance/CFO - 2017-05-29
Compliance Officer - 2023-07-31
Director TitleAgeSince
Chairman 55 -
Director/Board Member - 2011-07-14
Director/Board Member 41 2014-08-10
Change 5-day change 1-year change 3-year change Capi.($)
+2.74%+2.20%-20.68%-37.40% 11.14M
-0.71%+5.43%+79.39%+127.62% 1,119B
+1.04%+4.33%+53.43%+65.81% 651B
+0.18%+6.07%+27.94%+81.09% 468B
-1.38%+4.02%+42.52%+42.38% 374B
-0.52%+2.72%+25.21%+41.06% 302B
-1.06%+4.76%+2.00%+12.65% 259B
+0.35%+5.07%+52.75%+71.71% 238B
-0.53%+2.34%-18.53%-53.66% 208B
+0.19%+5.31%+28.16%+91.67% 181B
Average +0.03%+4.60%+27.22%+44.29% 379.99B
Weighted average by Cap. -0.22%+5.40%+45.93%+73.07%

Financials

2024 2025
Net sales 697M 7.28M 6.24M 5.83M 5.33M 10.07M 10.17M 69.04M 26.85M 350M 27.32M 26.73M 1.16B 662M 6.92M 5.93M 5.54M 5.07M 9.57M 9.67M 65.61M 25.51M 333M 25.97M 25.4M 1.1B
Net income 122M 1.28M 1.1M 1.03M 937K 1.77M 1.79M 12.13M 4.72M 61.48M 4.8M 4.7M 203M 124M 1.3M 1.11M 1.04M 950K 1.79M 1.81M 12.29M 4.78M 62.3M 4.87M 4.76M 206M
Net Debt -39.72M -415K -355K -333K -304K -574K -580K -3.93M -1.53M -19.94M -1.56M -1.52M -65.98M -39.77M -415K -356K -333K -304K -575K -581K -3.94M -1.53M -19.97M -1.56M -1.53M -66.08M
Logo Tyche Industries Limited
Tyche Industries Limited is an India-based company engaged in manufacturing of active pharmaceutical ingredients (APIs) and advanced intermediates of APIs. The Company operates through the Bulk Drugs segment. Its APIs include Sertraline HCI, Racecadotril, Palonosetron HCI, Silodosin, Solifenacin Succinate, Tamsulosin HCI, Tenofovir Disoproxil Fumarate, Tenofovir Alafenamide Fumarate, Atazanavir, Rupatadine Fumarate, Glucosamine HCI, Glucosamine Sulfate KCL, Glucosamine Sulfate NaCl, Nitrofurantoin Monohydrate, Nitrofurantoin Anhydrous and Nitrofurantoin Macrocrystal and others. Its intermediates include 4-(3,4-Dichlorophenyl)-1-tetralone, 1-Benzylpiperidine-4-Carboxaldehyde (BPCA), 3-Hydroxymethyl quinuclidine Hcl, and others. Its chiral intermediates include S-(+)-3-Quinuclidinol, R-(-)-3-Quinuclidinol and others. The Company's nutraceuticals include Glucosamine Hydrochloride, Glucosamine Sulfate Potassium Chloride and Glucosamine Sulfate Sodium Chloride.
Employees
162
Date Price Change Volume
26-08-24 106.85 +2.74% 3,804
26-08-21 ₹104.00 +0.87% 708
26-08-20 ₹103.10 -0.82% 481
26-08-19 ₹103.95 +0.43% 2,062
26-08-18 ₹103.50 -1.94% 3,219
  1. Stock Market
  2. Stocks
  3. TYCHE6 Stock